The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. / Mygind, Naja Dam; Harutyunyan, Marina J; Mathiasen, Anders Bruun; Ripa, Rasmus Sejersten; Thune, Jens Jacob; Gøtze, Jens Peter; Johansen, Julia S; Kastrup, Jens; The CLARICOR Trial Group.

I: Inflammation Research, Bind 60, Nr. 3, 2011, s. 281-7.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Mygind, ND, Harutyunyan, MJ, Mathiasen, AB, Ripa, RS, Thune, JJ, Gøtze, JP, Johansen, JS, Kastrup, J & The CLARICOR Trial Group 2011, 'The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease', Inflammation Research, bind 60, nr. 3, s. 281-7. https://doi.org/10.1007/s00011-010-0266-5, https://doi.org/10.1007/s00011-010-0266-5

APA

Mygind, N. D., Harutyunyan, M. J., Mathiasen, A. B., Ripa, R. S., Thune, J. J., Gøtze, J. P., ... The CLARICOR Trial Group (2011). The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. Inflammation Research, 60(3), 281-7. https://doi.org/10.1007/s00011-010-0266-5, https://doi.org/10.1007/s00011-010-0266-5

Vancouver

Mygind ND, Harutyunyan MJ, Mathiasen AB, Ripa RS, Thune JJ, Gøtze JP o.a. The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. Inflammation Research. 2011;60(3):281-7. https://doi.org/10.1007/s00011-010-0266-5, https://doi.org/10.1007/s00011-010-0266-5

Author

Mygind, Naja Dam ; Harutyunyan, Marina J ; Mathiasen, Anders Bruun ; Ripa, Rasmus Sejersten ; Thune, Jens Jacob ; Gøtze, Jens Peter ; Johansen, Julia S ; Kastrup, Jens ; The CLARICOR Trial Group. / The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. I: Inflammation Research. 2011 ; Bind 60, Nr. 3. s. 281-7.

Bibtex

@article{7ec0bebe4de44e4c84a5dbf833f3cc79,
title = "The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease",
abstract = "OBJECTIVE: The inflammatory biomarker YKL-40 is elevated and associated with mortality in patients with stable coronary artery disease (CAD). The aim was to investigate the influence of statin treatment and lipid status on serum YKL-40 and Hs-CRP in patients with stable CAD. DESIGN: Serum YKL-40, HsCRP, total cholesterol, HDL-c, LDL-c and triglycerides levels were measured in 404 statin treated and in 404 matched non-statin treated patients with stable CAD. RESULTS: YKL-40 was significantly higher in non-statin treated 110 µg/l (median) compared with 65 µg/l in statin treated (p ",
author = "Mygind, {Naja Dam} and Harutyunyan, {Marina J} and Mathiasen, {Anders Bruun} and Ripa, {Rasmus Sejersten} and Thune, {Jens Jacob} and G{\o}tze, {Jens Peter} and Johansen, {Julia S} and Jens Kastrup and {The CLARICOR Trial Group}",
year = "2011",
doi = "10.1007/s00011-010-0266-5",
language = "English",
volume = "60",
pages = "281--7",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Springer Basel AG",
number = "3",

}

RIS

TY - JOUR

T1 - The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease

AU - Mygind, Naja Dam

AU - Harutyunyan, Marina J

AU - Mathiasen, Anders Bruun

AU - Ripa, Rasmus Sejersten

AU - Thune, Jens Jacob

AU - Gøtze, Jens Peter

AU - Johansen, Julia S

AU - Kastrup, Jens

AU - The CLARICOR Trial Group

PY - 2011

Y1 - 2011

N2 - OBJECTIVE: The inflammatory biomarker YKL-40 is elevated and associated with mortality in patients with stable coronary artery disease (CAD). The aim was to investigate the influence of statin treatment and lipid status on serum YKL-40 and Hs-CRP in patients with stable CAD. DESIGN: Serum YKL-40, HsCRP, total cholesterol, HDL-c, LDL-c and triglycerides levels were measured in 404 statin treated and in 404 matched non-statin treated patients with stable CAD. RESULTS: YKL-40 was significantly higher in non-statin treated 110 µg/l (median) compared with 65 µg/l in statin treated (p 

AB - OBJECTIVE: The inflammatory biomarker YKL-40 is elevated and associated with mortality in patients with stable coronary artery disease (CAD). The aim was to investigate the influence of statin treatment and lipid status on serum YKL-40 and Hs-CRP in patients with stable CAD. DESIGN: Serum YKL-40, HsCRP, total cholesterol, HDL-c, LDL-c and triglycerides levels were measured in 404 statin treated and in 404 matched non-statin treated patients with stable CAD. RESULTS: YKL-40 was significantly higher in non-statin treated 110 µg/l (median) compared with 65 µg/l in statin treated (p 

U2 - 10.1007/s00011-010-0266-5

DO - 10.1007/s00011-010-0266-5

M3 - Journal article

C2 - 20972697

VL - 60

SP - 281

EP - 287

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

IS - 3

ER -

ID: 32108354